Who founded Corteria Pharmaceuticals?

Corteria Pharmaceuticals was founded by Philip Janiak, Marie-Laure Ozoux, Régis Olivier in 2021.

Who are Corteria Pharmaceuticals's investors?

Corteria Pharmaceuticals's investors include Fountain Healthcare Partners, Jeito Capital, Kurma Partners, OrbiMed, V-Bio Ventures, Omnes Capital, Invivo Capital Partners, LifeArc Ventures.

Corteria Pharmaceuticals

Founded 2021 · 27 employees on LinkedIn · 8 known investors

Find your way into Corteria Pharmaceuticals

210 people in our graph share verified history with the Corteria Pharmaceuticals team — schools, employers, funds. One of them is your warm intro.

Ward Capoenunlockedknows Marie-Laure Ozoux · together at Corteriapharma (overlapped)

×2knows the team · via Corteriapharma

×6knows the team · via Rhone-Poulenc Rorer

knows the team · via IAE Paris - Sorbonne Business School

×2knows the team · via Pierre and Marie Curie University

Corteria Pharma develops interceptive therapies aimed at treating subpopulations of patients with heart failure, sarcopenia, and obesity. The company operates in the biotech and drug development sector.

Biotech Digital Health Healthtech Longevity

Founders & leadership

Corteria Pharmaceuticals was founded in 2021 by Philip Janiak, Marie-Laure Ozoux, and Régis Olivier.

Philip JaniakFounder at Corteriapharma

Marie-Laure Ozoux Marie-Laure Ozoux has consulted in healthcare across preclinical and clinical drug development programs spanning oncology, immunology, and cardiovascular diseases, with expertise in translational medicine, biomarkers, and biotherapeutics development.

Régis OlivierFounder at Corteriapharma

Francesca C. Lawson

Mark Kowala

Eleonore JouannyFounder at Corteriapharma

Stéphane Durant des AulnoisFounder at Corteriapharma

Investors · 8

Fountain Healthcare Partners✓ confirmed by Corteria PharmaceuticalsDublin · $10.8M – $16.2M

How we know: Fountain Healthcare Partners's portfolio page · the company's own site · Not right? Tell us

Jeito Capital✓ confirmed by Corteria PharmaceuticalsParis

How we know: Jeito Capital's portfolio page · the company's own site · Not right? Tell us

Kurma Partners✓ confirmed by Corteria PharmaceuticalsParis · $162K – $10.8M

How we know: Kurma Partners's portfolio page · the company's own site · a partner's Signal profile · the VCSheet dataset · Not right? Tell us

OrbiMed✓ confirmed by Corteria PharmaceuticalsNew York · $1M – $75M

How we know: OrbiMed's portfolio page · the company's own site · the VCSheet dataset · Not right? Tell us

V-Bio Ventures✓ confirmed by Corteria PharmaceuticalsGhent · $270K – $2.2M

How we know: the company's own site · Not right? Tell us

Omnes Capital✓ confirmed by Corteria PharmaceuticalsParis

How we know: the company's own site · Not right? Tell us

Invivo Capital Partnerslisted by Invivo Capital PartnersBarcelona · $2.2M – $4.3M

LifeArc Ventureslisted by LifeArc VenturesLondon

Frequently asked questions

What does Corteria Pharmaceuticals do?: Corteria Pharma develops interceptive therapies aimed at treating subpopulations of patients with heart failure, sarcopenia, and obesity. The company operates in the biotech and drug development sector.
Who founded Corteria Pharmaceuticals?: Corteria Pharmaceuticals was founded by Philip Janiak, Marie-Laure Ozoux, Régis Olivier in 2021.
Who are Corteria Pharmaceuticals's investors?: Corteria Pharmaceuticals's investors include Fountain Healthcare Partners, Jeito Capital, Kurma Partners, OrbiMed, V-Bio Ventures, Omnes Capital, Invivo Capital Partners, LifeArc Ventures.